Ganfeng Lithium Co., Limited (1772.HK)
HKD 19.04
(4.27%)
HKD 19.04
(4.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 39.38 Billion CNY | 30.0% |
| 2022 | 30.29 Billion CNY | 135.02% |
| 2021 | 12.88 Billion CNY | 49.85% |
| 2020 | 8.6 Billion CNY | 48.24% |
| 2019 | 5.8 Billion CNY | 4.68% |
| 2018 | 5.54 Billion CNY | 40.13% |
| 2017 | 3.95 Billion CNY | 200.09% |
| 2016 | 1.31 Billion CNY | 104.58% |
| 2015 | 644.36 Million CNY | 13.71% |
| 2014 | 566.67 Million CNY | 24.5% |
| 2013 | 455.14 Million CNY | 91.81% |
| 2012 | 237.29 Million CNY | 162.85% |
| 2011 | 90.27 Million CNY | 55.86% |
| 2010 | 57.92 Million CNY | -47.31% |
| 2009 | 109.92 Million CNY | -18.21% |
| 2008 | 134.39 Million CNY | 67.58% |
| 2007 | 80.19 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 41.3 Billion CNY | 4.89% |
| 2024 Q2 | 45.37 Billion CNY | 9.85% |
| 2023 Q2 | 35.89 Billion CNY | 20.89% |
| 2023 Q1 | 29.69 Billion CNY | -1.98% |
| 2023 Q3 | 38.77 Billion CNY | 8.02% |
| 2023 FY | 39.38 Billion CNY | 30.0% |
| 2023 Q4 | 39.38 Billion CNY | 1.56% |
| 2022 FY | 30.29 Billion CNY | 135.02% |
| 2022 Q1 | 14.72 Billion CNY | 14.23% |
| 2022 Q2 | 19.75 Billion CNY | 34.14% |
| 2022 Q3 | 25.69 Billion CNY | 30.1% |
| 2022 Q4 | 30.29 Billion CNY | 17.89% |
| 2021 Q3 | 10.46 Billion CNY | 16.71% |
| 2021 Q1 | 8.66 Billion CNY | 0.76% |
| 2021 FY | 12.88 Billion CNY | 49.85% |
| 2021 Q2 | 8.96 Billion CNY | 3.45% |
| 2021 Q4 | 12.88 Billion CNY | 23.17% |
| 2020 Q4 | 8.6 Billion CNY | -10.81% |
| 2020 Q2 | 7.74 Billion CNY | 10.77% |
| 2020 Q1 | 6.99 Billion CNY | 20.56% |
| 2020 FY | 8.6 Billion CNY | 48.24% |
| 2020 Q3 | 9.64 Billion CNY | 24.46% |
| 2019 Q1 | 5.54 Billion CNY | 0.04% |
| 2019 FY | 5.8 Billion CNY | 4.68% |
| 2019 Q4 | 5.8 Billion CNY | -0.43% |
| 2019 Q3 | 5.82 Billion CNY | -7.95% |
| 2019 Q2 | 6.33 Billion CNY | 14.16% |
| 2018 FY | 5.54 Billion CNY | 40.13% |
| 2018 Q1 | 3.98 Billion CNY | 0.84% |
| 2018 Q2 | 4.18 Billion CNY | 4.8% |
| 2018 Q3 | 4 Billion CNY | -4.2% |
| 2018 Q4 | 5.54 Billion CNY | 38.42% |
| 2017 Q2 | 2.59 Billion CNY | 34.7% |
| 2017 FY | 3.95 Billion CNY | 200.09% |
| 2017 Q4 | 3.95 Billion CNY | 26.35% |
| 2017 Q3 | 3.13 Billion CNY | 20.46% |
| 2017 Q1 | 1.92 Billion CNY | 46.37% |
| 2016 FY | 1.31 Billion CNY | 104.58% |
| 2016 Q1 | 1.03 Billion CNY | 60.19% |
| 2016 Q4 | 1.31 Billion CNY | 12.69% |
| 2016 Q2 | 1.01 Billion CNY | -1.51% |
| 2016 Q3 | 1.16 Billion CNY | 15.06% |
| 2015 Q2 | 661.85 Million CNY | 4.3% |
| 2015 FY | 644.36 Million CNY | 13.71% |
| 2015 Q4 | 644.36 Million CNY | -17.59% |
| 2015 Q3 | 781.91 Million CNY | 18.14% |
| 2015 Q1 | 634.55 Million CNY | 11.98% |
| 2014 Q2 | 406.4 Million CNY | 15.16% |
| 2014 FY | 566.67 Million CNY | 24.5% |
| 2014 Q4 | 566.67 Million CNY | 28.14% |
| 2014 Q3 | 442.22 Million CNY | 8.82% |
| 2014 Q1 | 352.88 Million CNY | -22.47% |
| 2013 Q4 | 455.14 Million CNY | 7.94% |
| 2013 FY | 455.14 Million CNY | 91.81% |
| 2013 Q1 | 317.64 Million CNY | 33.86% |
| 2013 Q2 | 409.82 Million CNY | 29.02% |
| 2013 Q3 | 421.67 Million CNY | 2.89% |
| 2012 Q1 | 110.12 Million CNY | 21.99% |
| 2012 FY | 237.29 Million CNY | 162.85% |
| 2012 Q2 | 125.47 Million CNY | 13.94% |
| 2012 Q3 | 125.69 Million CNY | 0.17% |
| 2012 Q4 | 237.29 Million CNY | 88.79% |
| 2011 FY | 90.27 Million CNY | 55.86% |
| 2011 Q1 | 67.06 Million CNY | 15.79% |
| 2011 Q3 | 118.37 Million CNY | 6.69% |
| 2011 Q2 | 110.95 Million CNY | 65.44% |
| 2011 Q4 | 90.27 Million CNY | -23.74% |
| 2010 FY | 57.92 Million CNY | -47.31% |
| 2010 Q2 | 151.6 Million CNY | 0.0% |
| 2010 Q4 | 57.92 Million CNY | -46.37% |
| 2010 Q3 | 108.01 Million CNY | -28.75% |
| 2009 Q4 | 109.92 Million CNY | 0.0% |
| 2009 FY | 109.92 Million CNY | -18.21% |
| 2008 FY | 134.39 Million CNY | 67.58% |
| 2007 FY | 80.19 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 229.69 Million HKD | -17045.585% |
| Lee & Man Chemical Company Limited | 1.22 Billion HKD | -3103.844% |